CONVERGE: Management of the Multimorbid Type 2 Diabetes Patient

The CONVERGE educational meeting has been developed to reinforce your knowledge of managing cardio-renal-metabolic conditions in patients with T2D. This is your opportunity to learn from the experts as you discuss the management of clinical case studies with your peers. Dr Weng Sam is a Consultant Endocrinologist with special interests in diabetes, general endocrinology and bone metabolism and will be presenting the meeting.

By the end of this meeting, you will be able to:

- Assess and manage modifiable risk factors in patientswith T2D to reduce overall CVD risk

-Identify and screen appropriate patients for CKDaccording to the latest clinical guideline recommendations,including the importance of the urine albumin: creatinine ratio

- Implement a patient-centred approach to CKD management in the context of T2D

-Refute some common myths about SGLT2 inhibitors